Figure -3 - available via license: Creative Commons Attribution 4.0 International
Content may be subject to copyright.
Download
View publication
Evolution of Target lesion A. (A) Target lesion A before application of the THC-rich Cannabis ointment. (B) Target lesion A after 60 days of using THC-rich Cannabis ointment.

Evolution of Target lesion A. (A) Target lesion A before application of the THC-rich Cannabis ointment. (B) Target lesion A after 60 days of using THC-rich Cannabis ointment.

Source publication
Figure -1 Target lesions on day zero (D0). (A) Target lesion A...
Figure -2 Target lesions after 28 days of the beginning of the study....
Figure -3 Evolution of Target lesion A. (A) Target lesion A before...
Figure -4 Evolution of Target Lesion B. (A) Target lesion B on the...
EFFICACY OF TETRAHYDROCANNABINOL-RICH CANNABIS OINTMENT IN A CHILD WITH RECCESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA: CASE REPORT
Article
Full-text available
  • Jan 2024
Epidermolysis Bullosa (EB) is characterized by epithelial fragility with blistering and the presence of pain and chronic pruritus. Studies demonstrate the potential of cannabinoids in the treatment of dermatological disorders, presenting anti-inflammatory action, pruritus control, and analgesic effect. In addition, two case series of patients with...
Cite
Download full-text

Context in source publication

Context 1
... the end of the 28 days of application of the products, the blinding was removed and due to the marked improvement in the healing process and in the symptoms of pain, pruritus, and overall quality of life, the THC-rich Cannabis ointment began to be also applied to Target Lesion A. Over the course of two months, the THCrich Cannabis ointment was applied daily to both lesions and no adverse reactions or side effects were observed during this entire follow-up period. Target Lesion A, which was initially treated with placebo, achieved a marked improvement in its healing process, with almost complete reepithelialization (Figure 3). ...